From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement

Regorafenib-induced hand-foot skin reaction in an adolescent

Last Updated: Wednesday, May 21, 2025

In this case report, an adolescent with metastatic osteosarcoma developed severe, grade 3 regorafenib-induced hand-foot skin reaction (HFSR). This HFSR limited her ability to ambulate. The case demonstrates management involving supportive measures and temporary discontinuation of regorafenib, highlighting the absence of standard pediatric guidelines.

 

Pediatric Dermatology
Advertisement
News & Literature Highlights
Advertisement
Advertisement